Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026 Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026 Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026 Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025 Talphera Announces the Appointment of Joe Todisco to Board of Directors Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial Talphera Announces Second Quarter 2025 Financial Results and Provides Corporate Update Talphera to Host Second Quarter Financial Results and Corporate Update Call and Webcast on Thursday, August 14, 2025